Source: Υπουργείο Υγείας (CY) Publisher: OM PHARMA S.A., R. da Indústria, 2 – Quinta Grande, 2610-088 Аmadora Portugal
Dicynone 250.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
Ampoule for injection: Etamsylate 250 mg.
Excipients with a know effect: antiox. (E223) 0.8 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Etamsylate |
Etamsylate is a synthetic antihaemorrhagic and angioprotective drug acting on the first step of haemostasis (endothelium-platelet interaction). By improving platelet adhesiveness and restoring capillary resistance, it is able to reduce bleeding time and blood losses. |
| List of Excipients |
|---|
|
Sodium metabisulfite |
Colourless glass-ampoules, glass type I.
Packs of 4, 20, 100 ampoules.
Not all pack sizes may be marketed.
OM PHARMA S.A., R. da Indústria, 2 – Quinta Grande, 2610-088 Аmadora – Portugal
10494
Date of first authorisation: 18 July 2001
| Drug | Countries | |
|---|---|---|
| DICYNONE | Cyprus, Ecuador, Estonia, France, Lithuania, Mexico, Singapore, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
